pta20230130008
Business news for the stock market

OMRON Corporation: Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023 (U.S. GAAP)

[ PDF ]

Kyoto (pta008/30.01.2023/09:40 UTC+1)

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31,2023 (U.S. GAAP)

OMRON Corporation (6645)

Exchanges Listed: Tokyo

URL: https://www.omron.com/global/en/

Representative: Yoshihito Yamada, President and CEO

Contact: Toyoharu Tamoi, Executive Officer, Senior General Manager, Global Finance and Accounting HQ

Telephone: +81-75-344-7070

Filing of Quarterly Securities Report (Shihanki hokokusho)(scheduled): February 10, 2023

Start of Distribution of Dividends (scheduled):-

Preparation of Supplementary Materials for the Quarterly
Financial Results: Yes

Holding of Presentation of Quarterly Financial Results: Yes (Financial results presentation held via online streaming and teleconference for investors on January 30)

Note: This document has been translated from the Japanese original as a guide to non-Japanese investors and contains forward-looking statements that are based on managements' estimates, assumptions and projections at the time of publication. A number of factors could cause actual results to differ materially from expectations.

Note: Figures are rounded to the nearest million yen.

1. Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023

(April 1, 2022 – December 31, 2022)

(1) Sales and Income (cumulative) (Percentages represent changes compared with the same period of the previous fiscal year.)

Net salesOperating incomeIncome before income taxes Net income attributable
to OMRON shareholders
Nine months endedMillion yen%Million yen%Million yen%Million yen%
December 31, 2022637,97714.272,8549.070,66110.950,51712.7
December 31, 2021558,60919.066,85857.563,73136.244,81532.2

Note: Comprehensive income: Nine months ended December 31, 2022: 70,493 million yen (7.5% change);
Nine months ended December 31, 2021: 65,599 million yen (59.1% change)

Net income per share attributable to OMRON
shareholders, basic
Net income per share attributable to OMRON
shareholders, diluted
Nine months endedYenYen
December 31, 2022253.94
December 31, 2021222.53

(2) Consolidated Financial Position

Total assetsNet assetsShareholders' equityShareholders'
equity ratio
Million yenMillion yenMillion yen%
December 31, 2022944,462711,584708,92675.1
March 31, 2022930,629667,971665,22771.5

2. Dividends

Dividends per share
First quarter-endFirst half-endThird quarter-endFiscal year-endTotal
YenYenYenYenYen
Fiscal year ended
March 31, 2022
46.0046.0092.00
Fiscal year ending
March 31, 2023
49.00
Fiscal year ending
March 31, 2023
(projected)
49.00 98.00

Note: Revisions since the most recently announced dividend forecast: No

3. Projected Results for the Year Ending March 31, 2023 (April 1, 2022 – March 31, 2023)(Percentages represent changes compared with the same period of the previous fiscal year.)

Net salesOperating incomeIncome before income taxesNet income attributable to OMRON shareholdersNet income per share attributable to OMRON shareholders, basic
Million yen%Million yen%Million yen%Million yen%Yen
Full-year880,00015.395,0006.490,0003.864,5005.0323.83

Note: Revisions since the most recently announced performance forecast: No

*Notes

(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries due to changes in the scope of consolidation): No

New: - company (company name) Excluded: - company (company name)

(2) Application of simplified accounting methods and/or special accounting methods: No

(3) Changes in accounting policy

(a) Changes in accounting policy accompanying revision of accounting standards, etc.: No

(b) Changes in accounting policy other than (a) above: No

(4) Number of shares issued and outstanding

[1] Number of shares outstanding at period-end (including treasury stock)December 31, 2022206,244,872 Year ended
March 31, 2022
206,244,872
[2] Treasury stock at period-endDecember 31, 20229,088,972 Year ended
March 31, 2022
7,053,647
[3] Average number of shares during the period (quarterly cumulative)Nine months ended December 31, 2022198,933,622 Nine months ended December 31, 2021201,390,043

Note: As of the end of the consolidated first nine months of the fiscal year ending March 31, 2023, 600,208 shares of OMRON stock held for Board Incentive Plan and Employee Stock Ownership Plan are included in period-end treasury stock. The average number of shares during the period includes treasury stock deducted in the calculation of net income per share attributable to OMRON shareholders.

*Quarterly summaries of consolidated financial results are not subject to review by certified public accountants or audit corporations.

*Commentary Regarding Appropriate Use of Projections of Results and Other Matters

1. Projections of results and future developments are based on information available to the Company at the time of writing, as well as certain assumptions judged by the Company to be reasonable. Various risks, uncertainties and other factors could cause actual results to differ materially from these projections.
For the assumptions that form the basis of the projected results and appropriate use, see 1. Qualitative Information on Quarterly Financial Results (2) Description of Information on Outlook, Including Consolidated Performance Forecast on P.5.

2. The Company applies the single step method for presentation of its Consolidated Financial Statements based on U.S. GAAP. However, to facilitate comparison with other companies, operating income on the Consolidated Statements of Operations is presented by subtracting selling, general and administrative expenses and research and development expenses from gross profit.

3. The Company plans to hold a presentation for investors and information session via online streaming and teleconference on Monday, January 30, 2023.

The following abbreviations of business segment names are used in the attached materials.

IAB: Industrial Automation Business

HCB: Healthcare Business

SSB: Social Systems, Solutions and Service Business

DMB: Devices & Module Solutions Business

*In connection with the start of our long-term vision beginning April 2022, the name of EMC: Electronic and Mechanical Components Business changed to DMB: Devices & Module Solutions Business beginning with the fiscal year ending March 31, 2023. The new segments are used in these financial statements for consistency.

Table of Contents

1. Qualitative Information on Quarterly Financial ResultsP.2
(1) Description of Results of OperationsP.2
(2) Description of Information on Outlook, Including Consolidated Performance ForecastP.5
2. Quarterly Consolidated Financial Statements and NotesP.6
(1) Quarterly Consolidated Balance SheetsP.6
(2) Quarterly Consolidated Statements of Operations and Quarterly Consolidated Statements of Comprehensive IncomeP.8
(3) Consolidated Statements of Cash FlowsP.10
(4) Notes Regarding Consolidated Financial StatementsP.11
(Notes Regarding Assumptions of Going Concern)P.11
(Notes in the Event of Significant Changes in Shareholders' Equity)P.11
(Segment Information)P.12

1. Qualitative Information on Quarterly Financial Results

(1) Description of Results of Operations

General Overview

OMRON Group sales increased year on year for the cumulative consolidated third quarter (April through December 2022). Sales in the first quarter (April through June) were impacted significantly by the Shanghai lockdowns, mainly in the Industrial Automation Business. However, sales increased significantly year on year due to a recovery in production and the rapid ramp-up of supply capacity in the second quarter and later to respond to heavy order backlogs.

Gross profit margin was affected by factors including soaring materials prices and a decline in capacity utilization at the main plant of our Industrial Automation Business in the first quarter. However, we narrowed the year-on-year decline in gross profit ratio throughout the first half through ongoing company-wide efforts to improve the value-added ratio, including price optimizations. We continued with active investing for future growth to achieve the goals of our medium-term management plan (SF 1st Stage).

As a result, operating income rose year on year. Both sales and operating income marked a record high for any cumulative consolidated third quarter.

Consolidated results for the cumulative consolidated third quarter of fiscal 2022 were as follows.

(Billions of yen, except exchange rate data and percentages)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Change
Net sales558.6638.0+14.2%

Gross profit

[% of net sales]

256.4

[45.9%]

286.8

[45.0%]

+11.9%

[-0.9%pt]

Operating income

[% of net sales]

66.9

[12.0%]

72.9

[11.4%]

+9.0%

[-0.5%pt]

Income before income taxes63.770.7+10.9%
Net income attributable to OMRON shareholders44.850.5+12.7%
Average USD exchange rate (Yen)111.0135.7+24.7
Average EUR exchange rate (Yen)130.8140.3+9.5
Average CNY exchange rate (Yen)17.219.8+2.6


Results by Business Segment

IAB (Industrial Automation Business)

(Billions of yen, %)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Change
Sales to external customers310.6359.1+15.6%
Operating income57.964.5+11.4%

Note: Due to a revision of business management classifications, certain businesses of the IAB have been transferred to the DMB beginning with the fiscal year ending March 2023. Accordingly, the Company reclassified results for the fiscal year ended March 2022 under this new categorization for presentation herein.

Sales

Capital investment trends in the manufacturing industry indicate a risk of slowdown in the near term. However, demand for semiconductor production equipment, electric vehicles (EVs), and rechargeable batteries, on which we focus, remained steady.

Under these circumstances, we continued to accelerate efforts to strengthen supply capacity against the backdrop of a heavy order backlog. As a result, sales for the cumulative consolidated third quarter rose significantly year on year.

Operating Income

Despite the impact of lower factory utilization rates in the first quarter, higher material and logistics costs, and continued execution of growth investments, the segment posted a significant increase in operating income year on year due to the large increase in sales.

HCB (Healthcare Business)

(Billions of yen, %)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Change
Sales to external customers101.1106.7+5.6%
Operating income16.213.1-19.3%

Sales

Demand, mainly for blood pressure monitors, remained sluggish, affected by declining consumer confidence in response to global inflation. Demand was also impacted by dealer closures and stagnation in our distribution networks due to the Zero-COVID policy in China.

Despite these circumstances, we captured needs associated with growing health consciousness globally, while foreign exchange rates also provided a positive impact. As a result, sales rose year on year.

Operating Income

Despite efforts to curb fixed costs and optimize prices, operating income declined significantly year on year due to soaring materials prices and continued investments in future growth.

SSB (Social Systems, Solutions and Service Business)

(Billions of yen, %)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Change
Sales to external customers55.263.9+15.6%
Operating income (loss)(0.9)(0.2)

Sales

The Energy Solutions Business continued to experience firm demand for renewable energy-related solutions, mainly for captive consumption, due to factors including soaring energy costs. With the recovery in the number of railway users, the Public Transportation System Business saw the beginnings of a recovery in customer investment demand in the second quarter.

As a result, sales increased significantly year on year.

Operating Income (loss)

Despite the foreign exchange impact of foreign currency-denominated purchases, operating loss narrowed year on year due to higher sales and continued efforts to optimize prices.

DMB (Devices & Module Solutions Business)

(Billions of yen, %)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Change
Sales to external customers89.2105.0+17.7%
Operating income8.213.5+64.1%

Note: Due to a revision of business management classifications, certain businesses of the IAB have been transferred to the DMB beginning with the fiscal year ending March 2023. Accordingly, the Company reclassified results for the fiscal year ended March 2022 under this new categorization for presentation herein.

Sales

Although there were signs of a global slowdown in parts for the consumer industry, demand remained strong for products in which the business focuses, including solar power generation, storage batteries, and other energy-related products, as well as semiconductor inspection equipment-related products.

In response to this rising demand, we improved supply chains, resulting in a significant increase in sales year on year.

Operating Income

Despite the impact of soaring raw material prices and other factors, operating income increased significantly year on year, mainly due to a significant increase in sales, as well as efforts to optimize prices and improve productivity.

(2) Description of Information on Outlook, Including Consolidated Performance Forecast

We recognize that the risk of a global economic slowdown in the business environment surrounding the OMRON Group will increase in the fourth quarter, particularly for uncertainties related to demand in the Chinese market. We also expect the yen to gain more strength in the fourth quarter compared to our previous forecast.

Despite this business environment, the OMRON Group expects both net sales and operating income for the year to be in line with our prior forecasts in response to our efforts to strengthen supply capacity to meet heavy order backlog in the Industrial Automation Business and Devices & Module Solutions Business, as well as through company-wide price optimization and other measures to improve gross profit margin.

In light of these circumstances, we left full-year consolidated performance forecasts unrevised from the forecast announced previously (October 26, 2022).

We set exchange rate assumptions for the fourth quarter to USD1 = JPY125.0, EUR1 = JPY135.0, and CNY1 = JPY19.0. (The assumed exchange rates used for the fourth quarter in our previous forecast were USD1 = JPY140.0, EUR1 = 140.0, and CNY1 = 20.0.)


2. Quarterly Consolidated Financial Statements and Notes

(1) Quarterly Consolidated Balance Sheets

(Millions of yen)

As of
March 31, 2022
As of
December 31, 2022
% %
ASSETS
Current assets 482,90551.9 467,87349.5
Cash and cash equivalents 155,484 87,564
Notes and accounts receivable-trade 151,820 159,340
Allowance for doubtful receivables (798) (1,039)
Inventories 141,935 187,445
Assets held for sale 363 2
Other current assets 34,101 34,561
Property, plant and equipment, net 122,09813.1 123,66913.1
Investments and other assets 325,62635.0 352,92037.4
Right-of-use assets under operating leases 39,746 37,899
Goodwill 39,718 43,179
Investments in and advances to affiliates 124,691 134,557
Investment securities 43,757 42,275
Leasehold deposits 7,815 8,001
Prepaid benefit cost 14,391 15,179
Deferred income taxes 18,116 25,553
Other assets 37,392 46,277
Total assets 930,629100.0 944,462100.0


(Millions of yen)

As of
March 31, 2022
As of
December 31, 2022
% %
LIABILITIES
Current liabilities 211,67222.7 188,18219.9
Notes and accounts payable-trade 86,827 97,248
Short-term debt 20,000
Accrued expenses 48,365 40,294
Income taxes payable 5,657 4,934
Short-term operating lease liabilities 11,549 11,309
Other current liabilities 39,274 34,397
Deferred income taxes 2,1770.2 2,5550.3
Termination and retirement benefits 8,1940.9 3,3640.4
Long-term operating lease liabilities 28,5673.1 26,5482.8
Other long-term liabilities 12,0481.3 12,2291.3
Total liabilities 262,65828.2 232,87824.7
NET ASSETS
Shareholders' equity 665,22771.5 708,92675.1
Common stock 64,1006.9 64,1006.8
Capital surplus 100,65210.8 98,15910.4
Legal reserve 24,5032.6 24,7362.6
Retained earnings 517,56655.6 558,10159.1
Accumulated other comprehensive income (loss) 13,0131.4 32,3343.4
Foreign currency translation adjustments 33,908 48,400
Pension liability adjustments (19,930) (16,044)
Net gains (losses) on derivative instruments (965) (22)
Treasury stock (54,607)(5.8) (68,504)(7.3)
Noncontrolling interests 2,7440.3 2,6580.2
Total net assets 667,97171.8 711,58475.3
Total liabilities and net assets 930,629100.0 944,462100.0

(2) Quarterly Consolidated Statements of Operations and Quarterly Consolidated Statements of Comprehensive Income

(Quarterly Consolidated Statements of Operations)

(Nine months ended December 31, 2022)

(Millions of yen)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
% %
Net sales 558,609 100.0 637,977 100.0
Cost of sales 302,227 54.1 351,200 55.0
Gross profit 256,382 45.9 286,777 45.0
Selling, general and administrative expenses 156,467 28.0 177,568 27.9
Research and development expenses 33,057 5.9 36,355 5.7
Operating income 66,858 12.0 72,854 11.4
Other expenses, net 3,127 0.6 2,193 0.3
Income before income taxes 63,731 11.4 70,661 11.1
Income taxes 17,139 3.1 19,074 3.0
Equity in loss of affiliates 1,209 0.2 467 0.1
Net income 45,383 8.1 51,120 8.0
Net income attributable to noncontrolling interests 568 0.1 603 0.1
Net income attributable to OMRON shareholders 44,815 8.0 50,517 7.9

Note: Other expenses, net for the nine months ended December 2021 includes impairment loss of JPY3,384 million on goodwill related to NS Industria de Aparelhos Medicos LTDA. in Brazil, which was acquired under our Healthcare Business

(Quarterly Consolidated Statements of Comprehensive Income)

(Nine months ended December 31, 2022)

(Millions of yen)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Net income 45,383 51,120
Other comprehensive income, net of tax
Foreign currency translation adjustments 17,813 14,544
Pension liability adjustments 2,325 3,886
Net gains (losses) on derivative instruments 78 943
Other comprehensive income 20,216 19,373
Comprehensive income 65,599 70,493
(Breakdown)
Comprehensive income attributable to
noncontrolling interests
594 655
Comprehensive income attributable to
OMRON shareholders
65,005 69,838

(3) Consolidated Statements of Cash Flows

(Millions of yen)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Operating Activities:
1.Net income 45,383 51,120
2.

Adjustments to reconcile net income to net cash provided by
operating activities:
(1)Depreciation and amortization 17,355 19,777
(2)Decrease (increase) in notes and accounts receivable-trade 5,447 (3,891)
(3)Increase in inventories (27,419) (43,703)
(4)Increase in notes and accounts payable-trade 8,834 9,103
(5)Others, net (2,288) 1,929 (12,164) (30,878)
Net cash provided by operating activities 47,312 20,242
Investing Activities:
1.Purchases of investment securities (4,271) (1,911)
2.Capital expenditures (19,553) (27,983)
3.Proceeds from sale of property, plant and equipment 456 1,430
4.Increase in investments in and loans to affiliates, net (217) (9,976)
5.Others, net (390) (186)
Net cash used in investing activities (23,975) (38,626)
(Reference) Free cash flows 23,337 (18,384)
Financing Activities:
1.Net decrease in net borrowings of short-term debt (20,000)
2.Dividends paid by the Company (17,754) (18,912)
3.Acquisition of treasury stock (31,422) (17,900)
4.Others, net (437) (4)
Net cash used in financing activities (49,613) (56,816)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 10,762 7,280
Net increase (decrease) in cash and cash equivalents (15,514) (67,920)
Cash and cash equivalents at beginning of the period 250,755 155,484
Cash and cash equivalents at end of the period 235,241 87,564

Note: Free cash flow is cash flow from operating activities plus cash flow from investing activities.

(4) Notes Regarding Consolidated Financial Statements

(Notes Regarding Assumptions of Going Concern)

None applicable

(Notes in the Event of Significant Changes in Shareholders' Equity)

None applicable

(Segment Information)

Business Segment Information

(Millions of yen)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Year-on-year
change
IABSales to external customers310,555359,073115.6%
Intersegment sales4,7685,217109.4%
Total net sales315,323364,290115.5%
Operating expenses257,444299,831116.5%
Operating income (loss)57,87964,459111.4%
HCBSales to external customers101,057106,720105.6%
Intersegment sales104205197.1%
Total net sales101,161106,925105.7%
Operating expenses84,95193,847110.5%
Operating income (loss)16,21013,07880.7%
SSBSales to external customers55,23463,855115.6%
Intersegment sales7,2759,421129.5%
Total net sales62,50973,276117.2%
Operating expenses63,42173,493115.9%
Operating income (loss)(912)(217)
DMBSales to external customers89,243105,030117.7%
Intersegment sales31,84537,642118.2%
Total net sales121,088142,672117.8%
Operating expenses112,886129,210114.5%
Operating income (loss)8,20213,462164.1%
Eliminations
& Corporate
Sales to external customers2,5203,299130.9%
Intersegment sales(43,992)(52,485)
Total net sales(41,472)(49,186)
Operating expenses(26,951)(31,258)
Operating income (loss)(14,521)(17,928)
ConsolidatedSales to external customers558,609637,977114.2%
Intersegment sales
Total net sales558,609637,977114.2%
Operating expenses491,751565,123114.9%
Operating income (loss)66,85872,854109.0%

Note: Due to a revision of business management classifications, certain businesses of the IAB have been transferred to the DMB beginning with the fiscal year ending March 2023. Accordingly, the Company reclassified results for the fiscal year ended March 2022 under this new categorization for presentation herein.

Sales by Geographical Region

(Millions of yen)

Nine months ended
December 31, 2021
Nine months ended
December 31, 2022
Year-on-year
change
IABJapan98,490106,864108.5%
Americas27,00338,589142.9%
Europe61,00368,601112.5%
Greater China90,098102,998114.3%
Southeast Asia and Others33,94041,984123.7%
Direct Exports2137176.2%
Total310,555359,073115.6%
HCBJapan21,02320,01495.2%
Americas17,87121,400119.7%
Europe16,13916,955105.1%
Greater China34,32234,22099.7%
Southeast Asia and Others11,35013,647120.2%
Direct Exports352484137.5%
Total101,057106,720105.6%
SSBJapan55,11963,835115.8%
Americas
Europe
Greater China7779.1%
Southeast Asia and Others
Direct Exports381334.2%
Total55,23463,855115.6%
DMBJapan27,11131,075114.6%
Americas12,03318,522153.9%
Europe11,48513,649118.8%
Greater China27,48029,112105.9%
Southeast Asia and Others11,02312,581114.1%
Direct Exports1119182.0%
Total89,243105,030117.7%
Eliminations
& Corporate
Japan2,5203,299130.9%
Americas
Europe
Greater China
Southeast Asia and Others
Direct Exports00
Total2,5203,299130.9%
ConsolidatedJapan204,263225,087110.2%
Americas56,90778,511138.0%
Europe88,62799,205111.9%
Greater China151,977166,337109.4%
Southeast Asia and Others56,31368,212121.1%
Direct Exports522625119.7%
Total558,609637,977114.2%

Note1: Due to a revision of business management classifications, certain businesses of the IAB have been transferred to the DMB beginning with the fiscal year ending March 2023. Accordingly, the Company reclassified results for the fiscal year ended March 2022 under this new categorization for presentation herein.

Note 2: Major countries or regions belonging to segments other than Japan are as follows:

(1) Americas: United States of America, Canada, Brazil

(2) Europe: Netherlands, Great Britain, Germany, France, Italy, Spain

(3) Greater China: China, Hong Kong, Taiwan

(4) Southeast Asia and Others: Singapore, Republic of Korea, India, Australia

(5) Direct Exports: Direct export transactions

(end)

Emitter: OMRON Corporation
Shiokoji Horikawa, Shimogyo-ku
600-8530 Kyoto
Japan
Contact Person: Jan Hutterer
Phone: +49 172 3462831
E-Mail: jan.hutterer@kirchhoff.de
Website: www.omron.com
ISIN(s): DE0008647488 (Share) JP3197800000 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Hannover, Stuttgart
Other Stock Exchanges: NASDAQ, Tokio
|